Market Overview

UPDATE: MannKind Posts Wider Q4 Loss

Related MNKD
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog
MannKind: FDA Delays Afrezza Decision by Three Months (Fox Business)

MannKind (NASDAQ: MNKD) posted a wider fourth-quarter loss.

MannKind posted a quarterly loss of $51.8 million, or $0.23 per share, versus a year-ago loss of $36.4 million, or $0.30 per share. However, analysts were expecting a loss of $0.17 per share.

It posted a loss of $169.4 million in 2012.

MannKind shares gained 1.56% to $2.60 in after-hours trading.

Posted-In: lossEarnings News

 

Most Popular

Related Articles (MNKD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free